interferonstimul
gene
isg
critic
control
viru
infect
new
antivir
isg
continu
identifi
character
role
viral
pathogenesi
also
explor
detail
current
understand
isg
impact
viral
pathogenesi
come
larg
studi
knockout
mice
isol
exampl
human
clinic
data
review
outlin
recent
develop
contribut
variou
isg
viral
diseas
outcom
vivo
interferonstimul
gene
isg
critic
control
viru
infect
new
antivir
isg
continu
identifi
character
role
viral
pathogenesi
also
explor
detail
current
understand
isg
impact
viral
pathogenesi
come
larg
studi
knockout
mice
isol
exampl
human
clinic
data
review
outlin
recent
develop
contribut
variou
isg
viral
diseas
outcom
vivo
interferon
ifn
secret
cytokin
impact
numer
host
process
well
known
antivir
antiprolif
properti
among
three
main
ifn
famili
type
ifnab
iii
ifnl
ifn
consid
primari
antivir
ifn
although
type
ii
ifng
wellcharacter
antivir
effect
ifn
transcript
activ
highli
orchestr
sequenc
signal
event
compos
viral
sensor
adaptor
protein
kinas
transcript
factor
figur
newli
synthes
ifn
secret
infect
cell
bind
cognat
receptor
initi
signal
jakstat
pathway
result
transcript
induct
interferonstimul
gene
isg
encod
direct
antivir
effector
molecul
potenti
posit
neg
regul
ifn
signal
host
respons
genomewid
transcript
profil
identifi
hundr
isg
recent
function
screen
effort
ectop
overexpress
gene
silenc
begun
catalog
antivir
isg
identifi
target
mechanist
character
isg
character
mechan
gener
target
conserv
aspect
viral
infect
exampl
includ
isg
modul
nucleic
acid
integr
oasrnas
l
apobec
famili
member
viru
entri
protein
translat
pkr
ifit
famili
member
viru
egress
tetherin
function
major
antivir
isg
howev
remain
unknown
inde
determin
mechan
antivir
isg
major
goal
futur
research
innat
immun
moreov
recent
screen
studi
provid
target
mechanist
character
addit
question
remain
vitro
isg
studi
predict
physiolog
relev
function
antivir
molecul
vivo
role
ifn
viral
pathogenesi
well
establish
mice
human
type
ifn
receptor
knockout
ifnar
knockout
mice
highli
suscept
numer
virus
mice
defect
ifn
isg
product
due
genet
ablat
rigi
cga
mav
also
exhibit
enhanc
viral
pathogenesi
similarli
human
inborn
defici
nemo
trif
defect
ifn
respons
often
highli
suscept
one
viral
diseas
diseas
outcom
mice
human
variou
genet
defici
strongli
implic
ifn
extens
isg
primari
gene
control
replic
spread
virus
vivo
howev
hundr
known
isg
rel
character
vivo
contribut
antivir
immun
respons
like
due
sever
reason
first
breadth
isg
respons
uncov
use
genomewid
transcript
profil
decad
ago
second
public
recent
isg
screen
effort
rel
hundr
isg
character
antivir
phenotyp
vitro
sinc
decis
carri
genet
studi
mice
typic
requir
strong
rational
valid
vitro
studi
vivo
target
limit
gene
third
gene
control
ifn
product
eg
signal
eg
attract
target
genet
ablat
mice
sinc
absenc
would
priori
predict
confer
strong
viral
phenotyp
contrast
delet
singl
isg
larg
pool
ifninduc
gene
carri
inher
risk
detect
viral
phenotyp
due
redund
isg
effector
system
nonetheless
subset
downstream
isg
target
genet
disrupt
mice
promis
result
tabl
data
studi
provid
new
insight
isg
specif
distinct
class
viru
uniqu
cell
tissu
type
effector
studi
year
subject
recent
review
briefli
pkr
known
inhibitor
cellular
viral
mrna
translat
involv
varieti
cellular
process
includ
inflamm
apoptosi
sever
member
oa
enzym
famili
activ
doublestrand
rna
catalyz
format
oligoadenyl
activ
cellular
rnase
l
degrad
viral
genom
dynaminlik
gtpase
appear
target
viral
nucleocapsid
result
viral
inhibit
prior
establish
replic
inbr
strain
laboratori
mice
defici
function
protein
express
suscept
influenza
viru
infect
nonlaboratori
wild
type
strain
thu
isg
knockout
made
standard
mous
background
must
minim
consid
function
doubl
knockoutof
isg
interest
studi
shown
mice
defici
rnase
l
pkr
rang
pathogen
phenotyp
respons
numer
virus
virus
test
mice
includ
encephalomyocard
viru
vesicular
stomat
viru
herp
simplex
viru
type
coxsackieviru
west
nile
viru
murin
coronaviru
vaccinia
viru
depend
studi
pathogen
outcom
mani
virus
typic
includ
increas
mortal
higher
viremia
andor
viral
burden
variou
tissu
acceler
onset
clinic
diseas
howev
effect
univers
sinc
rnasel
mice
suscept
wild
type
mice
retrovir
infect
rnasel
x
pkr
knockout
exhibit
subclin
phenotyp
infect
sindbi
viru
mice
natur
mutat
socal
flv
flaviviru
resist
gene
also
well
character
suscept
rang
flavivirus
taken
togeth
vivo
studi
establish
role
pkr
antivir
oa
system
control
pathogen
virus
highlight
virusspecif
inhibitori
natur
isg
promyelocyt
leukemia
pml
protein
origin
discov
part
oncogen
fusion
protein
retino
acid
receptor
alpha
patient
acut
promyelocyt
leukemia
encod
pml
ifninduc
protein
organ
format
structur
distinct
nuclear
bodi
compos
perman
protein
daxx
well
number
transient
protein
atm
pml
bodi
regul
wide
rang
cellular
process
includ
respons
dna
damag
stress
apoptot
stimuli
viral
infect
regard
latter
antivir
mechan
pml
cell
cultur
appear
vari
depend
viru
exampl
pmlmediat
antivir
function
includ
inhibit
viral
transcript
sequestr
viral
protein
reduct
ifn
antivir
efficaci
formerli
pml
mice
challeng
lymphocyt
choriomening
viru
lcmv
increas
viral
titer
observ
spleen
compar
wild
type
mice
mice
also
exhibit
sever
footpad
swell
reaction
subcutan
intrafootpad
inocul
knockout
mice
infect
hepatotrop
strain
lcmv
pronounc
termin
immunpatholog
hepat
correl
elev
liver
transaminas
level
observ
mice
infect
low
dose
lcmv
intracerebr
inocul
exhibit
sever
cytotox
cellmedi
choriomening
compar
wild
type
mice
recent
studi
implic
pml
bind
protein
transcript
factor
plzf
encod
critic
regul
express
subset
isg
ifn
respons
mice
suscept
emcv
infect
wild
type
mice
protect
ifn
treatment
prior
semliki
forest
viru
sfv
infect
accordingli
sfv
titer
log
higher
numer
organ
mice
compar
wild
type
vivo
studi
provid
direct
evid
pml
relat
pathway
contribut
control
viral
spread
immunopatholog
outcom
certain
viral
infect
interferon
stimul
gene
encod
small
ubiquitinlik
molecul
well
character
antivir
properti
recent
comprehens
review
discuss
function
activ
contribut
innat
immun
respons
vitro
vivo
brief
numer
antivir
function
includ
inhibit
viru
releas
isgyl
viral
host
protein
immunomodulatori
cytokinelik
properti
unconjug
form
mice
challeng
least
ten
virus
mani
infect
mice
show
increas
mortal
compar
wild
type
mice
studi
mice
lack
conjug
enzym
indic
conjug
requir
antivir
activ
virus
eg
influenza
viru
dispens
virus
chikv
complex
function
highlight
recent
identif
human
inherit
defici
patient
found
increas
suscept
mycobacteri
viral
diseas
phenotyp
correl
impair
ifng
immun
mediat
secret
may
uniqu
role
immun
respons
speciesspecif
interferoninduc
protein
tetratricopeptid
repeat
ifit
famili
ifninduc
transmembran
protein
famili
ifitm
famili
aggress
studi
recent
year
protein
subject
sever
recent
review
thu
highlight
latest
develop
respect
role
effector
viral
pathogenesi
address
human
mous
ifit
famili
consist
human
addit
member
found
mous
ifit
famili
member
varieti
antivir
mechan
includ
translat
inhibit
recognit
viral
rna
lack
methyl
recognit
viral
rna
contain
triphosph
mice
well
character
respect
enhanc
suscept
mutant
virus
wnv
poxviru
coronaviru
lack
omethyltransferas
activ
mice
recent
gener
shown
highli
suscept
vsvmediat
neuropathogenesi
lethal
challeng
neurotrop
coronaviru
wnv
mice
show
greater
sign
clinic
diseas
accompani
increas
infect
central
nervou
system
studi
support
role
control
replic
pathogen
outcom
neurotrop
virus
highlight
differenti
vivo
function
relat
ifit
famili
member
ifitm
famili
consist
four
human
six
mous
protein
highli
homolog
presum
structur
relat
howev
exhibit
preferenti
antivir
specif
appear
link
mechan
action
gener
ifitm
shown
inhibit
earli
viral
entri
step
numer
studi
implic
virion
fusion
specif
thought
dictat
part
cellular
locat
virion
fusion
exampl
late
endosom
lysosom
ifitm
protein
origin
shown
potent
inhibit
influenza
viru
sever
flavivirus
list
target
virus
continu
grow
mice
recent
gener
show
fulmin
viral
pneumonia
strike
mortal
phenotyp
challeng
influenza
viru
exhibit
otherwis
low
pathogen
wild
type
mice
similar
result
obtain
mice
lack
entir
ifitm
locu
mice
also
shown
suscept
respiratori
syncyti
viru
note
laboratori
iftim
strain
also
function
mice
strike
pathogen
phenotyp
influenza
viru
must
therefor
consid
context
doubl
genotyp
hundr
human
isg
test
vitro
antivir
influenza
viru
appear
two
potent
thu
mous
like
extrem
exampl
innat
isgmedi
immunodefici
least
context
influenza
viru
infect
notabl
one
isg
effector
link
pathogen
outcom
viral
infect
human
genet
survey
patient
hospit
season
influenza
show
enrich
minor
allel
snp
gener
splice
variant
reduc
antivir
efficaci
human
clinic
data
strongli
support
mous
studi
help
solidifi
antivir
effector
critic
control
pathogen
outcom
certain
viral
infect
viperin
encod
radic
sam
domaincontain
molecul
divers
antivir
activ
appear
tie
lipid
biosynthet
fatti
acid
metabol
pathway
vitro
viperin
implic
control
number
virus
includ
human
cytomegaloviru
influenza
viru
sindbi
viru
alphaviru
flavivirus
wnv
dengu
viru
vivo
mice
challeng
influenza
viru
wnv
chikungunya
viru
alphaviru
lethal
challeng
influenza
viru
show
viperin
knockout
wild
type
mice
similar
respect
mortal
rate
viral
titer
lung
lung
patholog
contrast
mice
suscept
wnv
chikv
infect
compar
wild
type
mice
footpad
model
chikv
infect
mice
exhibit
enhanc
mortal
howev
mice
show
higher
viru
replic
footpad
increas
viremia
blood
pronounc
joint
swell
subcutan
edema
subcutan
intracrani
challeng
wnv
mice
higher
rate
mortal
increas
viral
replic
brain
spinal
cord
thu
respect
positivestrand
rna
virus
flaviviru
alphaviru
vivo
studi
larg
corrobor
vitro
find
lack
distinct
phenotyp
mice
influenza
viru
infect
stand
contrast
vitro
studi
may
due
numer
reason
includ
experiment
paramet
vivo
studi
compensatori
action
addit
isg
vivo
cell
type
specif
viperin
action
mice
strerol
biosynthet
pathway
recent
implic
antivir
immun
natur
occur
oxysterol
synthes
cholesterol
enzym
cholesterol
mice
human
metabolom
genet
screen
independ
uncov
potent
antivir
lipid
mediat
modul
lipid
composit
like
inhibit
viru
infect
earli
life
cycl
either
fusion
postentri
step
inde
sever
envelop
virus
suscept
inhibit
nonenvelop
adenoviru
challeng
murin
gammaherpesviru
mice
suscept
infect
also
direct
antivir
effect
replic
human
mous
model
infect
studi
establish
role
suppress
viru
replic
vivo
howev
addit
studi
mice
need
evalu
contribut
control
viral
pathogenesi
retrovir
restrict
factor
known
ifninduc
retroviru
restrict
factor
sever
target
gene
delet
mice
includ
human
seven
gene
best
character
respect
antivir
function
encod
cytosin
deaminas
restrict
deleteri
modif
revers
transcrib
viral
dna
sinc
mice
one
gene
presum
singl
gene
would
confer
antiretrovir
activ
mice
similar
human
homolog
inde
mice
infect
moloney
murin
leukemia
viru
mmlv
show
higher
level
infect
bone
marrow
spleen
moreov
loss
one
copi
result
rapid
develop
cell
leukemia
separ
studi
mice
infect
friend
retroviru
follow
system
ifna
treatment
wild
type
mice
ifn
treatment
significantli
reduc
viral
load
plasma
provir
load
spleen
bone
marrow
effect
compromis
mice
togeth
studi
suggest
contribut
significantli
ifninduc
antivir
effect
retrovirus
mice
dtnp
hydrolas
reduc
concentr
intracellular
dntp
pool
activ
implic
abil
restrict
retrovirus
noncycl
cell
two
variant
knockout
mice
gener
assess
role
effector
control
retrovir
infect
vivo
notabl
mice
exhibit
sever
autoimmun
diseas
characterist
human
aicardigoutier
syndrom
patient
mutat
use
differ
experiment
system
vector
studi
show
level
control
vector
transduct
howev
pathogenesi
rel
new
mous
model
address
tetherin
encod
human
membran
bound
protein
inhibit
viral
particl
releas
cell
surfac
origin
identifi
block
releas
tetherin
shown
similar
activ
envelop
virus
mice
recent
gener
challeng
sever
virus
system
infect
tetherin
knockout
mice
mmlv
result
slightli
higher
statist
signific
viral
burden
spleen
compar
wild
type
mice
strain
also
similar
tissu
viral
burden
system
infect
murin
cytomegaloviru
vsv
surprisingli
local
intranas
infect
vsv
influenza
b
viru
result
lower
viral
titer
lung
knockout
mice
compar
wild
type
earli
time
point
postinfect
anoth
unexpect
result
indic
mice
secret
less
ifn
wild
type
mice
respons
viral
challeng
suggest
tetherin
may
play
role
ifn
induct
addit
pathogenesi
studi
need
perform
mice
singl
studi
highlight
potenti
complex
phenotyp
antivir
function
tetherin
mice
recent
year
pace
discoveri
isgmedi
antivir
mechan
rapidli
increas
new
antivir
isg
identifi
character
contribut
immun
respons
vivo
need
address
major
gene
modul
ifn
product
signal
target
delet
mice
rel
downstream
isg
effector
knockout
exist
isg
target
shown
observ
phenotyp
respect
viral
pathogenesi
although
phenotyp
typic
modest
compar
mice
lack
major
ifn
signal
compon
unexpect
given
presum
redund
isg
effector
system
addit
insight
isg
mechan
vivo
may
obtain
cross
isg
knockout
mice
background
therebi
preclud
interfer
endogen
ifn
signal
altern
isg
transgen
knockin
onto
background
may
help
determin
isg
suffici
inhibit
virus
vivo
approach
would
complement
current
knockout
strategi
mostli
assess
necess
isg
host
antivir
respons
moreov
vitro
vivo
isg
studi
date
focus
singl
gene
isol
either
ectop
express
gene
silenc
delet
move
forward
new
approach
understand
combinatori
natur
isg
interact
network
need
may
accomplish
proteom
studi
cell
cultur
multipl
gene
delet
mice
perhap
via
recent
crispr
technolog
nonetheless
fact
singl
isg
delet
observ
pathogen
phenotyp
vivo
suggest
gene
provid
critic
function
protect
host
viral
diseas
may
therefor
valid
target
develop
novel
antivir
therapeut
